Fuling Technology
001356
KLT
831689
Hand Enterprise Solutions
300170
4
GRANDTECH
835184
5
Doushen(Beijing) Education & Technology Inc.
300010
US Stock MarketDetailed Quotes
RGEN Repligen
- 167.900
- +1.060+0.64%
Close Jan 23 16:00 ET
- 168.570
- +0.670+0.40%
Post 17:39 ET
9.36BMarket Cap-1199.29P/E (TTM)
168.650High162.820Low373.92KVolume164.870Open166.840Pre Close62.29MTurnover0.72%Turnover Ratio266.51P/E (Static)55.77MShares211.13052wk High4.77P/B8.72BFloat Cap113.50052wk Low--Dividend TTM51.93MShs Float327.320Historical High--Div YieldTTM3.49%Amplitude0.688Historical Low166.593Avg Price1Lot Size
About Repligen Company
Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. Europe, and Asia Pacific Region or Other geographical segments. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.
Company Profile
SymbolRGEN
Company NameRepligen
Listing DateMay 6, 1986
Founded1981
CEOMr. Olivier Loeillot
MarketNASDAQ
Employees1783
Fiscal Year Ends12-31
Address41 Seyon Street,Building 1, Suite 100
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02453
Phone1-781-250-0111
Websitehttp://www.repligen.com
Company Executives
- Name
- Position
- Salary
- Olivier Loeillot
- Director, President and Chief Executive Officer
- 5.45M
- James R. Bylund
- Chief Operating Officer
- 3.74M
- Jason K. Garland
- Chief Financial Officer
- 2.03M
- Christine Gebski
- Senior Vice President, Filtration and Chromatography
- 1.66M
- Ralf Kuriyel, PhD
- Senior Vice President, Research and Development
- 1.66M
- Tony J. Hunt
- Executive Chairman of the Board
- 7.93M
- Nicolas M. Barthelemy
- Independent Director
- 307.84K
- Karen A. Dawes, M.A.
- Lead Independent Director
- 431.12K
- Dr. Rohin Mhatre, PhD
- Independent Director
- 287.84K
- Margaret A. Pax
- Independent Director
- --
- Carrie Eglinton Manner
- Independent Director
- 287.84K
- Dr. Martin D. Madaus,PhD
- Independent Director
- 453.50K
- Dr. Konstantin Konstantinov, PhD
- Independent Director
- 282.84K
- Glenn P. Muir
- Independent Director
- 322.84K
Trending Stocks
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Stocks & Industries to Watch Under Trump's Second Presidency
Key takeaways Tech stocks underwent substantial growth due to tax cuts and reduced corporate regulations in Trump's first term along with defense and aerospace
Discussing
December CPI comes in as expected, is that enough?
U.S. December CPI rose 2.9% year-on-year, aligning with expectations but marking a three-month inflation increase trend. The market reacted
In One Chart
Jan 15 22:05
Here's the Breakdown for December CPI, in One Chart